Klaricid Paediatric

Clarithromycin, the active ingredient in Klaricid Paediatric, is a macrolide antibiotic presented as a pediatric oral suspension for oral use. It treats bacterial infections in children. GNH USA supplies Klaricid Paediatric as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is used to treat bacterial infections in pediatric patients across several common disease categories.

- Acute bacterial sinusitis: reduces infection and alleviates sinus symptoms. - Community‑acquired pneumonia: effective against susceptible respiratory pathogens. - Acute otitis media: clears middle‑ear bacterial infection. - Skin and soft‑tissue infections: treats bacterial skin infections such as impetigo and cellulitis.

Clarithromycin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional episodes after dosing. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort. - Altered taste: metallic or bitter sensation. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: severe colitis. - Hepatotoxicity: elevated liver enzymes or jaundice. - QT interval prolongation: risk of cardiac arrhythmias. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Cardiac arrhythmias: irregular heart rhythms in susceptible individuals.

Before prescribing Klaricid Paediatric, consider the following safety measures.

- Assess renal function: adjust use in patients with impaired kidney function. - Monitor liver enzymes: watch for signs of hepatotoxicity during therapy. - Avoid in known macrolide hypersensitivity: discontinue if allergic reaction occurs. - Use caution with QT‑prolonging agents: monitor cardiac status. - Discuss pregnancy and breastfeeding: evaluate risks with the prescriber. - Store at room temperature: keep in the original container, protect from moisture and light.

Clarithromycin can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Cisapride: risk of serious cardiac arrhythmias. - Pimozide: may cause QT prolongation and arrhythmias. - Ergot alkaloids: increased risk of ergotism. - Theophylline: elevated plasma levels leading to toxicity.

Moderate Interactions (Monitor Closely): - Statins (especially simvastatin): increased risk of myopathy. - Warfarin: potential enhancement of anticoagulant effect. - Carbamazepine: reduced clarithromycin levels, decreasing efficacy. - Phenytoin: may alter drug metabolism, requiring dose adjustments.